These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 11240034)
21. The spectrum of neurologic disease associated with anti-GM1 antibodies. Sadiq SA; Thomas FP; Kilidireas K; Protopsaltis S; Hays AP; Lee KW; Romas SN; Kumar N; van den Berg L; Santoro M Neurology; 1990 Jul; 40(7):1067-72. PubMed ID: 2162499 [TBL] [Abstract][Full Text] [Related]
22. Reactivity of a human monoclonal anti-GM1 and anti-GD1b IgM antibody with human neurons in cultures. Jauberteau MO; Brindel I; Baumann N; Preud'homme JL J Neuroimmunol; 1993 Oct; 48(1):53-7. PubMed ID: 8227308 [TBL] [Abstract][Full Text] [Related]
23. T cell-dependent activity of ganglioside GM1-specific B cells in Guillain-Barré syndrome and multifocal motor neuropathy in vitro. Heidenreich F; Leifeld L; Jovin T J Neuroimmunol; 1994 Jan; 49(1-2):97-108. PubMed ID: 8294565 [TBL] [Abstract][Full Text] [Related]
24. Anti-GM1 ganglioside antibodies in Parkinson's disease. Zappia M; Crescibene L; Bosco D; Arabia G; Nicoletti G; Bagalà A; Bastone L; Napoli ID; Caracciolo M; Bonavita S; Di Costanzo A; Gambardella A; Quattrone A Acta Neurol Scand; 2002 Jul; 106(1):54-7. PubMed ID: 12067330 [TBL] [Abstract][Full Text] [Related]
25. Trophic effect of cholera toxin B subunit in cultured cerebellar granule neurons: modulation of intracellular calcium by GM1 ganglioside. Wu G; Lu ZH; Nakamura K; Spray DC; Ledeen RW J Neurosci Res; 1996 May; 44(3):243-54. PubMed ID: 8723763 [TBL] [Abstract][Full Text] [Related]
26. Cryptogenic partial epilepsies with anti-GM1 antibodies: a new form of immune-mediated epilepsy? Bartolomei F; Boucraut J; Barrié M; Kok J; Dravet C; Viallat D; Bernard D; Gastaut JL Epilepsia; 1996 Oct; 37(10):922-6. PubMed ID: 8822688 [TBL] [Abstract][Full Text] [Related]
28. Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell-derived model. Harschnitz O; van den Berg LH; Johansen LE; Jansen MD; Kling S; Vieira de Sá R; Vlam L; van Rheenen W; Karst H; Wierenga CJ; Pasterkamp RJ; van der Pol WL Ann Neurol; 2016 Jul; 80(1):71-88. PubMed ID: 27130524 [TBL] [Abstract][Full Text] [Related]
29. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants. Salazar-Grueso EF; Routbort MJ; Martin J; Dawson G; Roos RP Ann Neurol; 1990 May; 27(5):558-63. PubMed ID: 2113790 [TBL] [Abstract][Full Text] [Related]
30. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254 [TBL] [Abstract][Full Text] [Related]
31. The sensitivity and specificity of anti-GM1 antibody testing. Taylor BV; Gross L; Windebank AJ Neurology; 1996 Oct; 47(4):951-5. PubMed ID: 8857725 [TBL] [Abstract][Full Text] [Related]
32. Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy. Nobile-Orazio E; Giannotta C; Musset L; Messina P; Léger JM J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):754-8. PubMed ID: 23907602 [TBL] [Abstract][Full Text] [Related]
33. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies]. Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060 [TBL] [Abstract][Full Text] [Related]
34. Induction of human IgM and IgG anti-GM1 antibodies in transgenic mice in response to lipopolysaccharides from Campylobacter jejuni. Lee G; Jeong Y; Wirguin I; Hays AP; Willison HJ; Latov N J Neuroimmunol; 2004 Jan; 146(1-2):63-75. PubMed ID: 14698848 [TBL] [Abstract][Full Text] [Related]
35. Interaction of ganglioside GM1 with the B subunit of cholera toxin modulates growth and differentiation of neuroblastoma N18 cells. Masco D; Van de Walle M; Spiegel S J Neurosci; 1991 Aug; 11(8):2443-52. PubMed ID: 1651376 [TBL] [Abstract][Full Text] [Related]
36. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications. Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116 [TBL] [Abstract][Full Text] [Related]
37. Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve. Corbo M; Quattrini A; Latov N; Hays AP Neurology; 1993 Apr; 43(4):809-14. PubMed ID: 7682302 [TBL] [Abstract][Full Text] [Related]
38. A sensitive flow cytometry method for anti-GM1 antibodies detection. Escande-Beillard N; David MJ; Portoukalian J; Pouget J; Azulay JP; Bernard D; Boucraut J J Neuroimmunol; 2002 Apr; 125(1-2):163-9. PubMed ID: 11960653 [TBL] [Abstract][Full Text] [Related]
39. Autoantibodies to GM1 and GQ1bα are not biological markers of Alzheimer's disease. Miura Y; Miyaji K; Chai YL; Chen CL; Lai MK; Yuki N J Alzheimers Dis; 2014; 42(4):1165-9. PubMed ID: 25024341 [TBL] [Abstract][Full Text] [Related]
40. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Hirota N; Kaji R; Bostock H; Shindo K; Kawasaki T; Mizutani K; Oka N; Kohara N; Saida T; Kimura J Brain; 1997 Dec; 120 ( Pt 12)():2159-69. PubMed ID: 9448571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]